Delivery Order SPE2DB20D2014-SPE2DB24FA85Q
- Not listed
- This is a $7,069.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin medication. The order has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,635.26 firm-fixed-price delivery order contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin product. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,581.57, is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has a performance period through December 14, 2023 and is a firm fixed-price delivery order. No set-aside designation was used for this award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,028.38 firm fixed price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $1,604.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 28, 2023. This contract award is not designated as a set-aside. AmerisourceBergen...
- This federal contract award, valued at $1,024.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a medical product. This is a firm fixed-price delivery order contract with a completion date of May 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,024.32 firm fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Humalog 100 unit/mL KwikPen insulin products. The $1,718.76 firm-fixed-price contract has a completion date of July 7, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $1,024.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. There is no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,242.23 firm-fixed-price delivery order is for the supply of HUMALOG 200 UNIT/ML KWIKPEN 3ML, a critical diabetes medication. The contract has a completion date of November 1, 2024 and was awarded on October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA85QDelivery Order
This is a $1,024.32 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 1/22/24 |